SNAP25-AS1: A Potential Drug Target and Biomarker (G100131208)

Target Name: SNAP25-AS1

NCBI ID: G100131208

SNAP25-AS1

Other Name(s): SNAP25 antisense RNA 1

SNAP25-AS1: A Potential Drug Target and Biomarker

SNAP25-AS1 is a protein that is expressed in various tissues of the body, including the brain, heart, liver, and pancreas. It is a key regulator of the cell cycle and has been implicated in the development and progression of several diseases, including cancer. While the exact function of SNAP25-AS1 is not yet fully understood, research has shown that it plays a crucial role in the regulation of cell division and growth.

Potential Drug Target

The potential drug target for SNAP25-AS1 is based on its role in cell division and the regulation of the cell cycle. SNAP25-AS1 has been shown to interact with several key transcription factors, including TGF-β1, p21, and p53. These transcription factors are involved in regulating cell growth, apoptosis, and translation of new proteins. By interacting with these transcription factors, SNAP25-AS1 may be a useful target for drugs that are designed to inhibit cell division or inhibit the effects of transcription factors.

Biomarker

SNAP25-AS1 has also been shown to be a potential biomarker for several diseases, including cancer. The cell cycle is a key aspect of the development and progression of cancer, and changes in the cell cycle have been observed in many types of cancer. By measuring the expression of SNAP25-AS1, researchers may be able to determine the level of cell division and the presence of cancer cells. This information could be used to develop new diagnostic tests for cancer and to inform drug development for cancer therapies.

Clinical Applications

SNAP25-AS1 has been shown to be involved in the development and progression of several diseases, including cancer. For example, studies have shown that high levels of SNAP25-AS1 expression are associated with poor prognosis in patients with pancreatic ductal adenocarcinoma, a type of pancreatic cancer. Additionally, SNAP25-AS1 has been shown to be involved in the development of neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease.

In addition to its potential clinical applications, SNAP25-AS1 is also a potential drug target. The regulation of cell division and the cell cycle is a key aspect of the development and progression of many diseases, and SNAP25-AS1 may be a useful target for drugs that are designed to inhibit cell division or inhibit the effects of transcription factors. Further research is needed to fully understand the role of SNAP25-AS1 in the development and progression of diseases and to develop new treatments based on this protein.

Conclusion

SNAP25-AS1 is a protein that has been shown to play a crucial role in the regulation of cell division and growth. Its potential as a drug target and biomarker make it an attractive target for future research and development. Further studies are needed to fully understand the role of SNAP25-AS1 in the development and progression of diseases and to develop new treatments based on this protein.

Protein Name: SNAP25 Antisense RNA 1

The "SNAP25-AS1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SNAP25-AS1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets